Results 31 to 40 of about 50,613 (304)

Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients [PDF]

Farmacia Hospitalaria, 2019
Objective: To calculate the persistence, over a period of eight years, the retention rate of first and second-line of treatment with biological agents in patients with rheumatoid arthritis, spondyloarthritis and psoriatic arthritis and to compare ...
María Ángeles González-Fernández , Elena Villamañán , Inmaculada Jiménez-Nácher , Francisco Moreno , Alicia Herrero , Alejandro Balsa   +5 more
doaj   +1 more source

Treatment recommendations for psoriatic arthritis

, 2008
Objective: To develop comprehensive recommendations for the treatment of the various clinical manifestations of psoriatic arthritis (PsA) based on evidence obtained from a systematic review of the literature and from consensus opinion.
Gladman, D.D., GRAPPA, Fiorentino, David, Taylor, William J., de Vlam, K., Helliwell, P., Kavanaugh, Arthur, FitzGerald, Oliver, Gottlieb, A. B., Helliwell, Philip, McHugh, N.J., Gladman, Dafna D., Nash, P., Mease, P.J., Boehncke, W-H., McHugh, Neil J., Soriano, E.R., Gottlieb, Alice B., Gladman, D. D., Gottlieb, A.B., FitzGerald, O., Boehncke, Wolf-Henning, Taylor, W.J., McHugh, N. J., Ritchlin, C.T., Mease, Philip J., Mease, P. J., Nash, Peter, Soriano, Enrique R., Qureshi, A. A., Taylor, W. J., Ritchlin, Christopher T., Ritchlin, C. T., Kavanaugh, A., Qureshi, Abrar A., Qureshi, A.A., Boehncke, W. H., Fiorentino, D., Vlam, Kurt de, Soriano, E. R.   +39 more
core   +1 more source

Angiogenic gene expression and vascular density are reflected in ultrasonographic features of synovitis in early Rheumatoid Arthritis: an observational study. [PDF]

, 2015
INTRODUCTION: Neovascularization contributes to the development of sustained synovial inflammation in the early stages of Rheumatoid Arthritis. Ultrasound (US) provides an indirect method of assessing synovial blood flow and has been shown to correlate ...
Kelly, S, Maria DiCicco, Hands, RE, Frances Humby, Riahi, S, Nora Ng, Michele Bombardieri, Arti Mahto, Sudeh Riahi, Humby, F, DiCicco, M, Rebecca E Hands, Marrelli, A, Pitzalis, C, Stephen Kelly, Pyne, D, Lu Zou, Bombardieri, M, Mahto, A, Ng, N, Costantino Pitzalis, Zou, L, Debasish Pyne, Alessandra Marrelli   +23 more
core   +1 more source

Challenges in the Metabolomics-Based Biomarker Validation Pipeline

Metabolites
As end-products of the intersection between the genome and environmental influences, metabolites represent a promising approach to the discovery of novel biomarkers for diseases.
Shenghan Li, Nikita Looby, Vinod Chandran, Vathany Kulasingam   +3 more
doaj   +1 more source

Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis : report on five cases [PDF]

, 2008
Infliximab is a monoclonal antibody directed against TNF-alpha. It has been approved for use in rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriatic arthritis and plaque-type psoriasis.
Krüger, Ullrich, Thaçi, Diamant, Pätzold, Sylvie, Reich, Kristian, Bertsch, Hans Peter, Mössner, Rotraut, Mohr, Johannes   +6 more
core   +1 more source

Identification of a Single Nucleotide Polymorphism in NFKBIA with Different Effects on Psoriatic Arthritis and Cutaneous Psoriasis in China

Acta Dermato-Venereologica, 2018
Genome-wide association studies have recently identified a number of non-major histocompatibility complex regions associated with psoriatic arthritis.
Qing Zhao, Yonghu Sun, Xi’an Fu, Zhenzhen Wang, Gongqi Yu, Zhenhua Yue, Yaru Wang, Huimin Zhang, Chuan Wang, Hong Liu, Qing Yang, Furen Zhang   +11 more
doaj   +1 more source

Psoriatic arthritis: review of potential biomarkers predicting response to TNF inhibitors

, 2022
Psoriatic arthritis (PsA) is a chronic and painful inflammatory immune-mediated disease. It affects up to 40% of people with psoriasis and it is associated with several comorbidities such as obesity, diabetes, metabolic syndrome and hypertension.
Kuiper, JH, Amarasena, R., Kehoe, Oksana, Makos, Anaïs   +3 more
core   +1 more source

Longitudinal profiling of the gut microbiome in patients with psoriatic arthritis and ankylosing spondylitis: a multicentre, prospective, observational study [PDF]

, 2020
Background : Psoriasis is a chronic inflammatory disease of the skin affecting 2-3% ofUK population. 30% of people affected by psoriasis will develop a distinct form ofarthritis within 10 years of the skin condition onset.
Abraham, Sonya, Kelleher, Peter, Sengupta, Raj, Borghese, Federica, Marchesi, Julian, Miguens Blanco, Jesus, McHugh, Neil   +6 more
core   +1 more source

Chronic kidney disease in patients with psoriatic arthritis: a cohort study

RMD Open
Objectives Chronic kidney disease (CKD) is a comorbidity in psoriatic arthritis (PsA). We aimed to define the prevalence of CKD in patients with PsA, describe their long-term renal outcomes and identify risk factors for CKD development.Methods We ...
Dafna D Gladman, Vinod Chandran, Richard J Cook, Fadi Kharouf, Shangyi Gao, Shahad Al-Matar   +5 more
doaj   +1 more source

ENTHESITIS AND PSORIATIC ONYCHOPATHY AS A FACTOR FOR PREDICTION OF PSORIATIC ARTHRITIS IN PSORIASIS

Vestnik Dermatologii i Venerologii, 2018
Psoriatic arthritis is a psoriasis-related spondyloarthropathy that occurs in 20–30 % of patients with psoriasis. Psoriatic arthritis affects the patient’s quality of life indicators and are more often associated with disabilities of working age than ...
Tatyana G. Sidorcika, Viktor A. Linovs, Maya A. Radzina, Andris J. Rubins, Sylvester A. Rubins   +4 more
doaj   +1 more source